Laboratório Edol - Produtos Farmacêuticos, S.A.
Ana Correia de Matos is currently the Scientific Service Responsible person at Laboratório Edol - Produtos Farmacêuticos, S.A. Ana has experience in scientific training, regulatory affairs, and pharmaceutical technology. Ana also serves as an Invited Assistant Professor at the Faculty of Pharmacy of the University of Lisbon. Throughout their career, Ana has demonstrated expertise in areas such as pharmaceutical technology, biomaterials, and drug delivery systems. Additionally, Ana has a background in mechanical engineering, polymer/plastics engineering, and chemistry, with a focus on polymeric materials.
This person is not in any teams
Laboratório Edol - Produtos Farmacêuticos, S.A.
1 followers
Laboratório Edol – Produtos Farmacêuticos, S.A., is a Portuguese Pharmaceutical Company specialized in the development, production and marketing of pharmaceuticals, medical devices, cosmetic products and food supplements in the areas of ophthalmology, dermatology, ENT and dermocosmetic. Laboratório Edol produces, currently, about 3.5 million units per year and it has a settled capacity of about 7.2 million units per shift / year. Edol’s Production Department has modern equipment for manufacturing and packaging of the following pharmaceutical preparations: • Eye drops • Eye ointments • Eye gels • Comfort opthtalmic solutions • Ear drops • Creams • Ointments • Cutaneos Suspentions • Shampoos Laboratório Edol has focused its strategy in internationalization ever since 2005 and, presently, Edol exports for more than 15 countries all over the 4 Continents - Europe, Africa, Asia and Latin America. Laboratório Edol bases its success and constant growth in the qualification, competence and dedication of its employees. That is the reason why Edol is respected and acknowledged by its customers, physicians, pharmacists and nurses which allow us to say, with all proud, that Laboratório Edol is a reference company, currently market leader in the ophthalmology and with a solid and strong implementation in dermatology. For more information, please visit www.edol.pt